newsfilter
← Latest News
GlobeNewswire·

Medexus Pharmaceuticals Reports Financial and Operational Results for First Quarter Fiscal 2022

Continued strength in unit demand across key product lines Rupall unit demand growth of 44% for the 12 months ending June 30, 2021 Completion of enrollment for IXINITY® Phase 4 clinical pediatric trials Management to host conference